Cargando…

Neutrophil gelatinase‐associated lipocalin level is a prognostic factor for survival in rat and human chronic liver diseases

Chronic liver disease patients often have complications, such as hepatocellular carcinoma (HCC) and acute bacterial infection. Model for end‐stage liver disease and Child‐Pugh scores are useful prognostic factors for chronic liver diseases but not for all chronic conditions, such as HCC. Our investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshikawa, Kyoko, Iwasa, Motoh, Eguchi, Akiko, Kojima, Shinichi, Yoshizawa, Naohiko, Tempaku, Mina, Sugimoto, Ryosuke, Yamamoto, Norihiko, Sugimoto, Kazushi, Kobayashi, Yoshinao, Hasegawa, Hiroshi, Takei, Yoshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721464/
https://www.ncbi.nlm.nih.gov/pubmed/29404502
http://dx.doi.org/10.1002/hep4.1109
_version_ 1783284811529453568
author Yoshikawa, Kyoko
Iwasa, Motoh
Eguchi, Akiko
Kojima, Shinichi
Yoshizawa, Naohiko
Tempaku, Mina
Sugimoto, Ryosuke
Yamamoto, Norihiko
Sugimoto, Kazushi
Kobayashi, Yoshinao
Hasegawa, Hiroshi
Takei, Yoshiyuki
author_facet Yoshikawa, Kyoko
Iwasa, Motoh
Eguchi, Akiko
Kojima, Shinichi
Yoshizawa, Naohiko
Tempaku, Mina
Sugimoto, Ryosuke
Yamamoto, Norihiko
Sugimoto, Kazushi
Kobayashi, Yoshinao
Hasegawa, Hiroshi
Takei, Yoshiyuki
author_sort Yoshikawa, Kyoko
collection PubMed
description Chronic liver disease patients often have complications, such as hepatocellular carcinoma (HCC) and acute bacterial infection. Model for end‐stage liver disease and Child‐Pugh scores are useful prognostic factors for chronic liver diseases but not for all chronic conditions, such as HCC. Our investigative aim targeted the prognostic abilities of neutrophil gelatinase‐associated lipocalin (NGAL) in rat and human chronic liver diseases. Blood NGAL levels were measured by enzyme‐linked immunosorbent assay in rats with cirrhosis and 96 patients with chronic liver disease and HCC. We examined the correlation between blood NGAL levels and liver functions as well as survival. In our rat model, liver NGAL expression was assessed by immunostaining, real‐time quantitative polymerase chain reaction, and immunoblot. In rats with cirrhosis, blood NGAL levels were continuously and significantly elevated in the deceased group and were significantly correlated with liver functions. Liver NGAL, toll‐like receptor 4, and interleukin‐6 levels were increased in the deceased group compared to the survival group. Blood NGAL levels were significantly correlated with liver NGAL levels, indicating blood NGAL was derived from the liver. In patients with chronic liver disease, blood NGAL levels were associated with liver function and renal function. Blood NGAL levels were significantly increased in patients with chronic liver disease with HCC compared to without HCC. For the survival group, 38 out of 96 patients were dead in the average follow‐up period of 9.9 months. The patients with blood NGAL ≤119 ng/mL had significantly longer rates of survival compared to patients with blood NGAL >119 ng/mL. Conclusion: Blood NGAL predicts the survival rate in rat and human chronic liver diseases. Our findings suggest blood NGAL may be prognostic of survival in chronic liver diseases complicated by HCC. (Hepatology Communications 2017;1:946–956)
format Online
Article
Text
id pubmed-5721464
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57214642018-02-05 Neutrophil gelatinase‐associated lipocalin level is a prognostic factor for survival in rat and human chronic liver diseases Yoshikawa, Kyoko Iwasa, Motoh Eguchi, Akiko Kojima, Shinichi Yoshizawa, Naohiko Tempaku, Mina Sugimoto, Ryosuke Yamamoto, Norihiko Sugimoto, Kazushi Kobayashi, Yoshinao Hasegawa, Hiroshi Takei, Yoshiyuki Hepatol Commun Original Articles Chronic liver disease patients often have complications, such as hepatocellular carcinoma (HCC) and acute bacterial infection. Model for end‐stage liver disease and Child‐Pugh scores are useful prognostic factors for chronic liver diseases but not for all chronic conditions, such as HCC. Our investigative aim targeted the prognostic abilities of neutrophil gelatinase‐associated lipocalin (NGAL) in rat and human chronic liver diseases. Blood NGAL levels were measured by enzyme‐linked immunosorbent assay in rats with cirrhosis and 96 patients with chronic liver disease and HCC. We examined the correlation between blood NGAL levels and liver functions as well as survival. In our rat model, liver NGAL expression was assessed by immunostaining, real‐time quantitative polymerase chain reaction, and immunoblot. In rats with cirrhosis, blood NGAL levels were continuously and significantly elevated in the deceased group and were significantly correlated with liver functions. Liver NGAL, toll‐like receptor 4, and interleukin‐6 levels were increased in the deceased group compared to the survival group. Blood NGAL levels were significantly correlated with liver NGAL levels, indicating blood NGAL was derived from the liver. In patients with chronic liver disease, blood NGAL levels were associated with liver function and renal function. Blood NGAL levels were significantly increased in patients with chronic liver disease with HCC compared to without HCC. For the survival group, 38 out of 96 patients were dead in the average follow‐up period of 9.9 months. The patients with blood NGAL ≤119 ng/mL had significantly longer rates of survival compared to patients with blood NGAL >119 ng/mL. Conclusion: Blood NGAL predicts the survival rate in rat and human chronic liver diseases. Our findings suggest blood NGAL may be prognostic of survival in chronic liver diseases complicated by HCC. (Hepatology Communications 2017;1:946–956) John Wiley and Sons Inc. 2017-10-16 /pmc/articles/PMC5721464/ /pubmed/29404502 http://dx.doi.org/10.1002/hep4.1109 Text en © 2017 The Authors. Hepatology Communications published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Yoshikawa, Kyoko
Iwasa, Motoh
Eguchi, Akiko
Kojima, Shinichi
Yoshizawa, Naohiko
Tempaku, Mina
Sugimoto, Ryosuke
Yamamoto, Norihiko
Sugimoto, Kazushi
Kobayashi, Yoshinao
Hasegawa, Hiroshi
Takei, Yoshiyuki
Neutrophil gelatinase‐associated lipocalin level is a prognostic factor for survival in rat and human chronic liver diseases
title Neutrophil gelatinase‐associated lipocalin level is a prognostic factor for survival in rat and human chronic liver diseases
title_full Neutrophil gelatinase‐associated lipocalin level is a prognostic factor for survival in rat and human chronic liver diseases
title_fullStr Neutrophil gelatinase‐associated lipocalin level is a prognostic factor for survival in rat and human chronic liver diseases
title_full_unstemmed Neutrophil gelatinase‐associated lipocalin level is a prognostic factor for survival in rat and human chronic liver diseases
title_short Neutrophil gelatinase‐associated lipocalin level is a prognostic factor for survival in rat and human chronic liver diseases
title_sort neutrophil gelatinase‐associated lipocalin level is a prognostic factor for survival in rat and human chronic liver diseases
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721464/
https://www.ncbi.nlm.nih.gov/pubmed/29404502
http://dx.doi.org/10.1002/hep4.1109
work_keys_str_mv AT yoshikawakyoko neutrophilgelatinaseassociatedlipocalinlevelisaprognosticfactorforsurvivalinratandhumanchronicliverdiseases
AT iwasamotoh neutrophilgelatinaseassociatedlipocalinlevelisaprognosticfactorforsurvivalinratandhumanchronicliverdiseases
AT eguchiakiko neutrophilgelatinaseassociatedlipocalinlevelisaprognosticfactorforsurvivalinratandhumanchronicliverdiseases
AT kojimashinichi neutrophilgelatinaseassociatedlipocalinlevelisaprognosticfactorforsurvivalinratandhumanchronicliverdiseases
AT yoshizawanaohiko neutrophilgelatinaseassociatedlipocalinlevelisaprognosticfactorforsurvivalinratandhumanchronicliverdiseases
AT tempakumina neutrophilgelatinaseassociatedlipocalinlevelisaprognosticfactorforsurvivalinratandhumanchronicliverdiseases
AT sugimotoryosuke neutrophilgelatinaseassociatedlipocalinlevelisaprognosticfactorforsurvivalinratandhumanchronicliverdiseases
AT yamamotonorihiko neutrophilgelatinaseassociatedlipocalinlevelisaprognosticfactorforsurvivalinratandhumanchronicliverdiseases
AT sugimotokazushi neutrophilgelatinaseassociatedlipocalinlevelisaprognosticfactorforsurvivalinratandhumanchronicliverdiseases
AT kobayashiyoshinao neutrophilgelatinaseassociatedlipocalinlevelisaprognosticfactorforsurvivalinratandhumanchronicliverdiseases
AT hasegawahiroshi neutrophilgelatinaseassociatedlipocalinlevelisaprognosticfactorforsurvivalinratandhumanchronicliverdiseases
AT takeiyoshiyuki neutrophilgelatinaseassociatedlipocalinlevelisaprognosticfactorforsurvivalinratandhumanchronicliverdiseases